Fluoroquinolones represent a potent group of antibiotics that inhibit bacterial DNA replication by targeting the essential bacterial enzymes gyrase and topoisomerase IV. Inhibition of gyrase activity by quinolones involves the interaction of these drugs with the helicase component of bacterial gyrase. DNA tumour viruses also encode helicases that are essential for their DNA replication in the host.
Methods
In this study we have evaluated the effect of fluoroquinolones on viral DNA replication using the DNA tumour virus Simian virus 40 (SV40) as our model. Four different fluoroquinolones, namely, levofloxacin, trovafloxacin, ciprofloxacin and ofloxacin, were tested for their ability to inhibit viral DNA replication.
Results
We show here that all four quinolones tested were effective in the inhibition of SV40 plaque formation and DNA replication in CV1-P cells. In addition, we found that each of these quinolones was inhibitory to the helicase activity of SV40 large tumour antigen.
Conclusions
Fluoroquinolones and their derivates may therefore be useful in the treatment and/or prevention of infection by SV40-homologous human DNA viruses that encode helicase activity for their survival.
References
1.
SimmonsD.T.SV40 large T antigen functions in DNA replication and transformation.Adv Virus Res2000; 55: 75–134.
2.
CaputoA., Barbanti-BrodanoG., WangE., RicciardiR.P.Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens.Virology1986; 152: 459–465.
3.
TavisJ.E., FrisqueR.J.Altered DNA binding and replication activities of JC virus T-antigen mutants.Virology1991; 183: 239–250.
KojimaH., KaitaK.D., HawkinsK., UhanovaJ., MinukG.Y.Use of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failure.Antimicrob Agents Chemother2002; 46: 3280–3282.
6.
NegroF., MaleP.J., PerrinL., GiostraE., HadengueA.Treatment of chronic hepatitis C with alpha-interferon plus ofloxacin in patients not responding to alpha-interferon alone.J Hepatol1998; 29: 369–374.
7.
RichterS.N., PaluG.Inhibitors of HIV-1 Tat-mediated transactivation.Curr Med Chem2006; 13: 1305–1315.
8.
PortolaniM., PietrosemoliP., CermelliC.Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase.Antiviral Res1988; 9: 205–218.
9.
HigginsP.G., FluitA.C., SchmitzF.J.Fluoroquinolones: structure and target sites.Curr Drug Targets2003; 4: 181–190.
10.
SuginoA., HigginsN.P., BrownP.O., PeeblesC.L., CozzarelliN.R.Energy coupling in DNA gyrase and the mechanism of action of novobiocin.Proc Natl Acad Sci USA1978; 75: 4838–4842.
11.
KreuzerK.N., CozzarelliN.R.Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth.J Bacteriol1979; 140: 424–435.
12.
Froelich-AmmonS.J., OsheroffN.Topoisomerase poisons: harnessing the dark side of enzyme mechanism.J Biol Chem1995; 270: 21429–21432.
LevineC., HiasaH., MariansK.J.DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities.Biochim Biophys Acta1998; 1400: 29–43.
15.
WangJ.C.Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine.Q Rev Biophys1998; 31: 107–144.
16.
MariansK.J.Crawling and wiggling on DNA: structural insights to the mechanism of DNA unwinding by helicases.Structure Fold Des2000; 8: R227–235.
17.
Morais CabralJ.H., JacksonA.P., SmithC.V., ShikotraN., MaxwellA., LiddingtonR.C.Crystal structure of the breakage-reunion domain of DNA gyrase.Nature1997; 388: 903–906.
18.
LiD., ZhaoR., LilyestromW.Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen.Nature2003; 423: 512–518.
19.
SingletonM.R., SawayaM.R., EllenbergerT., WigleyD.B.Crystal structure of T7 gene 4 ring helicase indicates a mechanism for sequential hydrolysis of nucleotides.Cell2000; 101: 589–600.
20.
ShenL.L., PernetA.G.Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.Proc Natl Acad Sci USA1985; 82: 307–311.
21.
ShenL.L., MitscherL.A., SharmaP.N.Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model.Biochemistry1989; 28: 3886–3894.
22.
RichterS., ParolinC., PalumboM., PaluG.Antiviral properties of quinolone-based drugs.Curr Drug Targets Infect Disord2004; 4: 111–116.
